Table 1 Demographic and clinical characteristics of women and infants enrolled.
No (%) | ||
|---|---|---|
No. of mothers | 24 | |
No. of infantsa | 23 | |
Maternal age at 1st dose, median (IQR), y | 34 (33–39) | |
Mode of delivery | ||
Vaginal | 19 (79) | |
Exclusive breastfeeding at 1st dose | 15 (65) | |
Exclusive breastfeeding at 2nd dose 90 ± 1 days | 3 (13) | |
Gestational age, median (range), wks | 39 (33–41) | |
Preterm birth | 2 (8) | |
Birth weight, mean (SD), g | 3455 (440) | |
Infant age at 1st dose, median (IQR), wks | 21 (11–30) | |
After 1st dose | After 2nd dose | |
Reported reaction | 10 (41) | 18 (75) |
Injection-site pain | 5 (21) | 2 (8) |
Malaise | 1 (4) | 14 (58) |
Headache | 1 (4) | 7 (29) |
Fever | 0 | 4 (17) |
Diarrhea | 1 (4) | 0 |
Myalgia | 1 (4) | 5 (21) |
Nausea | 2 (8) | 2 (8) |
Rash | 0 | 1 (4) |
Adenitis | 0 | 1 (4) |
